HIGHLIGHTS
- who: Hajime Yasuda from the Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan have published the Article: Anti-myelin-associated-glycoprotein neuropathy successfully treated with tirabrutinib, in the Journal: (JOURNAL)
- what: The authors report a rituximab-refractory anti-MAG neuropathy patient successfully treated with tirabrutinib, a second generation Bruton tyrosine kinase (BTK) inhibitor.
SUMMARY
Anti-myelin-associated-glycoprotein (MAG) neuropathy is a distal, predominantly demyelinating, sensory or sensory-motor polyneuropathy most often developing in the context of an IgM-type monoclonal gammopathy due to monoclonal gammopathy of undetermined significance . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.